NCT02868268 2026-03-23
Neuroblastoma Precision Trial
New Approaches to Neuroblastoma Therapy Consortium
Active not recruiting
New Approaches to Neuroblastoma Therapy Consortium
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
British Columbia Cancer Agency